phosphorus has been researched along with dydrogesterone in 2 studies
| Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (dydrogesterone) | Trials (dydrogesterone) | Recent Studies (post-2010) (dydrogesterone) |
|---|---|---|---|---|---|
| 48,074 | 1,126 | 17,139 | 600 | 173 | 212 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amial'eva, EP; Lazebnik, LB; Malichenko, SB | 1 |
| Deng, Y; Ma, X; Sun, A; Wang, YF; Xue, W; Zhu, SY | 1 |
1 trial(s) available for phosphorus and dydrogesterone
| Article | Year |
|---|---|
Bone protection for early menopausal women in China: standard or half-dose estrogen with progestin? A one-year prospective randomized trail.
Topics: Alanine Transaminase; Alkaline Phosphatase; Bone Density; Calcium; Drug Therapy, Combination; Dydrogesterone; Endometrium; Estrogens; Estrogens, Conjugated (USP); Female; Femur Neck; Fractures, Bone; Humans; Lumbar Vertebrae; Middle Aged; Organ Size; Osteoporosis, Postmenopausal; Phosphorus; Progestins | 2019 |
1 other study(ies) available for phosphorus and dydrogesterone
| Article | Year |
|---|---|
[Vasoactive effects of femostone in women with metabolic postmenopausal syndrome].
Topics: Calcium; Cerebrovascular Circulation; Dydrogesterone; Estradiol; Female; Humans; Lipids; Metabolic Diseases; Middle Aged; Phosphorus; Platelet Aggregation; Postmenopause; Purines; Syndrome; Treatment Outcome; Vasodilation | 2000 |